Protagenic Therapeutics Inc
protagenic.comWhat Do They Do?
Develops peptide-based drug candidates for stress-related neuropsychiatric and mood disorders, including depression, anxiety and substance use disorders.
10-K for FY2026, filed Aug 14, 2026Protagenic Therapeutics, Inc. (together with its subsidiary, “Protagenic,” the “Company,” “we,” “our” or “us”) is a biopharmaceutical…View ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q1 FY2026, filed Aug 19, 2026
−$963.6KView ↗
- ▼ −81% (Loss)
- vs −$5.1M in Q1 FY2025
Who Do They Compete With?
Competes with Otsuka, AbbVie, Johnson & Johnson, and Sage Therapeutics
10-K for FY2026, filed Aug 14, 2026Brexpiprazole (Rexulti from Otsuka) is a dopamine (D2 receptor) partial stimulator (agonist) approved as an oral adjunctive TRD therapy.…View ↗
Loading...
